Sort by:

select Language:

Gap analysis: which diseases have treatments on the market or promise in the pipeline?

Access to Medicine Foundation, (2018)

When pharmaceutical companies take action to improve access to medicine, it has the largest impact on their own products. The Access to Medicine Index has identified which products those are – as well as future products still in development – for 20 of the world’s largest research-based pharmaceutical companies

Access to Medicines 2018. Fact Sheet

Access to Medicine Foundation, (2018)

The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis moves up into 2nd. Takeda rises furthest in 2018, jumping ten places to fifth Download the full report from (Large File 22 MB)

Medicines Patents, Access and Innovation

Brot für die Welt, (2016)

The growing challenges for people in low and middle-income countries to access new medicines. Analysis 58

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines

Médecins sans Frontières, (2016)

4th edition. This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to standardised questionnaires and the Global TB Drug Facility website.

Sources And Prices Of Selected Medicines for Children

Unicef, WHO, (2010)

Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition

Measuring medicine prices, availability, affordability and price components

World Health Organization; hai global, (2008)

2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been updated to reflect the wealth of practical experience in conducting medicine prices and availability surveys garnered in the project’s first two phases.

6 hits